View in EDS

Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.

Saved in:
Bibliographic Details
Title: Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.
Authors: Emanuelli A; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Souleyreau W; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Chouleur T; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Boeckx B; Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, 3000 Leuven, Belgium.; VIB Center for Cancer Biology, 3000 Leuven, Belgium., Pobiedonoscew Y; University of Bordeaux, INSERM, U1312 BRIC, Modeling Transformation and Resistance in Leukemia Laboratory, Bordeaux, France., Cooley L; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Derieppe MA; Animalerie Mutualisée, Service Commun des Animaleries, Université de Bordeaux, 33000 Bordeaux, France., Martineau J; Animalerie Mutualisée, Service Commun des Animaleries, Université de Bordeaux, 33000 Bordeaux, France., Ambrosetti D; Department of Pathology, University Côte d'Azur, CHU Nice, Nice, France., Bernhard JC; Urology Department, Bordeaux University Hospital, Bordeaux, France., Sawai CM; University of Bordeaux, INSERM, U1312 BRIC, Modeling Transformation and Resistance in Leukemia Laboratory, Bordeaux, France., Lambrechts D; Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, 3000 Leuven, Belgium.; VIB Center for Cancer Biology, 3000 Leuven, Belgium., Mathivet T; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Bikfalvi A; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France.
Source: IScience [iScience] 2025 May 26; Vol. 28 (6), pp. 112752. Date of Electronic Publication: 2025 May 26 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40538439
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Emanuelli+A%22">Emanuelli A</searchLink>; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France.<br /><searchLink fieldCode="AU" term="%22Souleyreau+W%22">Souleyreau W</searchLink>; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France.<br /><searchLink fieldCode="AU" term="%22Chouleur+T%22">Chouleur T</searchLink>; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France.<br /><searchLink fieldCode="AU" term="%22Boeckx+B%22">Boeckx B</searchLink>; Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, 3000 Leuven, Belgium.; VIB Center for Cancer Biology, 3000 Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Pobiedonoscew+Y%22">Pobiedonoscew Y</searchLink>; University of Bordeaux, INSERM, U1312 BRIC, Modeling Transformation and Resistance in Leukemia Laboratory, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Cooley+L%22">Cooley L</searchLink>; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France.<br /><searchLink fieldCode="AU" term="%22Derieppe+MA%22">Derieppe MA</searchLink>; Animalerie Mutualisée, Service Commun des Animaleries, Université de Bordeaux, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Martineau+J%22">Martineau J</searchLink>; Animalerie Mutualisée, Service Commun des Animaleries, Université de Bordeaux, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Ambrosetti+D%22">Ambrosetti D</searchLink>; Department of Pathology, University Côte d'Azur, CHU Nice, Nice, France.<br /><searchLink fieldCode="AU" term="%22Bernhard+JC%22">Bernhard JC</searchLink>; Urology Department, Bordeaux University Hospital, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Sawai+CM%22">Sawai CM</searchLink>; University of Bordeaux, INSERM, U1312 BRIC, Modeling Transformation and Resistance in Leukemia Laboratory, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Lambrechts+D%22">Lambrechts D</searchLink>; Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, 3000 Leuven, Belgium.; VIB Center for Cancer Biology, 3000 Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Mathivet+T%22">Mathivet T</searchLink>; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France.<br /><searchLink fieldCode="AU" term="%22Bikfalvi+A%22">Bikfalvi A</searchLink>; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724038%22">IScience</searchLink> [iScience] 2025 May 26; Vol. 28 (6), pp. 112752. <i>Date of Electronic Publication: </i>2025 May 26 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101724038 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-0042 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225890042%22">25890042 </searchLink><i>NLM ISO Abbreviation: </i>iScience <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40538439
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.isci.2025.112752
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 112752
    Titles:
      – TitleFull: Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Emanuelli A
      – PersonEntity:
          Name:
            NameFull: Souleyreau W
      – PersonEntity:
          Name:
            NameFull: Chouleur T
      – PersonEntity:
          Name:
            NameFull: Boeckx B
      – PersonEntity:
          Name:
            NameFull: Pobiedonoscew Y
      – PersonEntity:
          Name:
            NameFull: Cooley L
      – PersonEntity:
          Name:
            NameFull: Derieppe MA
      – PersonEntity:
          Name:
            NameFull: Martineau J
      – PersonEntity:
          Name:
            NameFull: Ambrosetti D
      – PersonEntity:
          Name:
            NameFull: Bernhard JC
      – PersonEntity:
          Name:
            NameFull: Sawai CM
      – PersonEntity:
          Name:
            NameFull: Lambrechts D
      – PersonEntity:
          Name:
            NameFull: Mathivet T
      – PersonEntity:
          Name:
            NameFull: Bikfalvi A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 05
              Text: 2025 May 26
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2589-0042
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: IScience
              Type: main
ResultId 1